First trimester screening for Down's syndrome using maternal serum PAPP-A and free beta=hCG in combination with fetal nuchal translucency thickness
- 1 August 1998
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 105 (8) , 917-920
- https://doi.org/10.1111/j.1471-0528.1998.tb10239.x
Abstract
The aim of this study was to evaluate the potential effectiveness of maternal serum pregnancy-associated plasma protein A (PAPP-A) and free beta-hCG in combination with nuchal translucency thickness in first trimester screening for Down's syndrome. Maternal serum levels of PAPP-A and free beta-hCG were assayed in stored sera from 32 Down's syndrome and 200 unaffected pregnancies. Fetal nuchal translucency was measured by ultrasound at the time of blood sampling. Screening of Down's syndrome using a combination of maternal age, PAPP-A, free beta-hCG and nuchal translucency would achieve a detection rate of 75.8% for a false positive rate of 5%.Keywords
This publication has 5 references indexed in Scilit:
- Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21Ultrasound in Obstetrics & Gynecology, 1997
- Serum screening for Down's syndrome between 8 and 14 weeks of pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Maternal age‐specific risks for trisomies at 9—14 weeks' gestationPrenatal Diagnosis, 1994
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988